Nihat Polat

Mechanisms of hepatic stellate cell activation

Association Between Nonalcoholic Fatty Liver Disease and Cardiovascular Risk in Obese Children and Adolescents

Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention

Targeting oxidative stress in disease: promise and limitations of antioxidant therapy

Global epidemiology and outcomes of acute kidney injury

Local and systemic effects of the multifaceted epicardial adipose tissue depot

Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease

Mechanisms of NAFLD development and therapeutic strategies

Liver Fibrogenesis in Non-Alcoholic Steatohepatitis

Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor?

Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association

The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm

Global burden of liver disease: 2023 update

Mechanisms of Key Innate Immune Cells in Early- and Late-Onset Preeclampsia

Epicardial fat and atrial fibrillation: current evidence, potential mechanisms, clinical implications, and future directions

NAFLD: A multisystem disease

Cardiovascular Disease and Myocardial Abnormalities in Nonalcoholic Fatty Liver Disease

Existing and potential therapeutic uses for N-acetylcysteine: The need for conversion to intracellular glutathione for antioxidant benefits

Heritability of non‐alcoholic fatty liver disease and association with abnormal vascular parameters: A twin study

AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease

Orthogonal Design of Experiments for Engineering of Lipid Nanoparticles for mRNA Delivery to the Placenta

2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

Effectiveness of Prevention Strategies for Contrast-Induced Nephropathy

2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons

The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

The Value of Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio for Detecting Early-onset Neonatal Sepsis

Effectiveness of N ‐Acetylcysteine for the Prevention of Contrast‐Induced Nephropathy: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials

Associations of Epicardial, Abdominal, and Overall Adiposity With Atrial Fibrillation

Irritable bowel syndrome is associated with novel inflammatory markers derived from hemogram parameters

New inflammatory markers in pre-eclampsia: echocardiographic epicardial fat thickness and neutrophil to lymphocyte ratio

Intrarenal application of N-acetylcysteine for the prevention of contrast medium-induced nephropathy in primary angioplasty

Coronary flow reserve is impaired in patients with nonalcoholic fatty liver disease: Association with liver fibrosis

New inflammatory predictors for non-valvular atrial fibrillation: echocardiographic epicardial fat thickness and neutrophil to lymphocyte ratio

Circulating vaspin levels and epicardial adipose tissue thickness are associated with impaired coronary flow reserve in patients with nonalcoholic fatty liver disease

Relationship Between Hematologic Indices and Global Registry of Acute Coronary Events Risk Score in Patients With ST-Segment Elevation Myocardial Infarction